Document Detail


Activation of phosphatidylinositol 3-kinase is required for transcriptional activity of F-type 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: assessment of the role of protein kinase B and p70 S6 kinase.
MedLine Citation:
PMID:  10861211     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Previous studies have demonstrated that the F isoform of<hsp sp=0.5>6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase(6PF2K/Fru-2,6-BPase) is transcriptionally regulated by growth factors. The aim of this study was to investigate the importance of the phosphatidylinositol 3-kinase (PI 3-kinase) pathway in the regulation of 6PF2K/Fru-2,6-BPase gene expression. We have completed studies using chemical inhibitors and expression vectors for the proteins involved in this signalling cascade. Treatment of cells with LY 294002, an inhibitor of PI 3-kinase, blocked the epidermal growth factor (EGF)-dependent stimulation of 6PF2K/Fru-2,6-BPase gene transcription. Transient transfection of a constitutively active PI 3-kinase was sufficient to activate transcription from the F-type 6PF2K/Fru-2,6-BPase promoter. In contrast, co-transfection with a dominant-negative form of PI 3-kinase completely abrogated the stimulation by EGF, and down-regulated the basal promoter activity. In an attempt to determine downstream proteins that lie between PI 3-kinase and 6PF2K/Fru-2,6-BPase gene expression, the overexpression of a constitutively active form of protein kinase B (PKB) was sufficient to activate 6PF2K/Fru-2,6-BPase gene expression, even in the presence of either a dominant-negative form of PI 3-kinase or LY 294002. The over-expression of p70/p85 ribosomal S6 kinase or the treatment with its inhibitor rapamycin did not affect 6PF2K/Fru-2,6-BPase transcription. We conclude that PI 3-kinase is necessary for the transcriptional activity of F-type 6PF2K/Fru-2,6-BPase, and that PKB is a downstream effector of PI 3-kinase directly involved in the regulation of 6PF2K/Fru-2,6-BPase gene expression.
Authors:
S Fernández de Mattos ; E de los Pinos E; M Joaquin; A Tauler
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The Biochemical journal     Volume:  349     ISSN:  0264-6021     ISO Abbreviation:  Biochem. J.     Publication Date:  2000 Jul 
Date Detail:
Created Date:  2001-01-26     Completed Date:  2001-07-19     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  2984726R     Medline TA:  Biochem J     Country:  England    
Other Details:
Languages:  eng     Pagination:  59-65     Citation Subset:  IM    
Affiliation:
Departament de Bioquímica i Biologia Molecular, Div. IV, Facultat de Farmàcia, Universitat de Barcelona, Av. Diagonal 643, E08028 Barcelona, Catalunya, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
1-Phosphatidylinositol 3-Kinase / antagonists & inhibitors,  metabolism*
Animals
Cells, Cultured
Chloramphenicol O-Acetyltransferase / metabolism
Chromones / pharmacology
Dose-Response Relationship, Drug
Down-Regulation
Enzyme Activation*
Enzyme Inhibitors / pharmacology
Epidermal Growth Factor / metabolism
Gene Expression Regulation, Enzymologic*
Genes, Dominant
Immunoblotting
Morpholines / pharmacology
Phosphofructokinase-2
Phosphoric Monoester Hydrolases / chemistry,  genetics,  metabolism*
Phosphotransferases (Alcohol Group Acceptor) / chemistry,  genetics,  metabolism*
Plasmids / metabolism
Promoter Regions, Genetic
Protein Isoforms
Protein-Serine-Threonine Kinases*
Proto-Oncogene Proteins / metabolism,  physiology*
Proto-Oncogene Proteins c-akt
Rats
Ribosomal Protein S6 Kinases / physiology*
Transcription, Genetic*
Transfection
Chemical
Reg. No./Substance:
0/Chromones; 0/Enzyme Inhibitors; 0/Morpholines; 0/Protein Isoforms; 0/Proto-Oncogene Proteins; 154447-36-6/2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one; 62229-50-9/Epidermal Growth Factor; EC 2.3.1.28/Chloramphenicol O-Acetyltransferase; EC 2.7.1.-/Phosphotransferases (Alcohol Group Acceptor); EC 2.7.1.105/Phosphofructokinase-2; EC 2.7.1.137/1-Phosphatidylinositol 3-Kinase; EC 2.7.11.1/Protein-Serine-Threonine Kinases; EC 2.7.11.1/Proto-Oncogene Proteins c-akt; EC 2.7.11.1/Ribosomal Protein S6 Kinases; EC 3.1.3.-/Phosphoric Monoester Hydrolases
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Processing of N-linked oligosaccharide depends on its location in the anion exchanger, AE1, membrane...
Next Document:  Identification of a nucleoside/nucleobase transporter from Plasmodium falciparum, a novel target for...